跳至主要内容
临床试验/CTRI/2023/09/057793
CTRI/2023/09/057793尚未招募2 期

Evaluation of clinical efficacy of Haridradi Tail snehpana in Apathyanimittaj prameha upadrava with special reference to endothelial inflammation in type II Diabetes Mellitus - NI

Dr Snehalkumar Prakash Patil0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Subjects having signs and symptoms of prameha explained in Ayurvedic tests.
  • Known patients of Type-II diabetes mellitus
  • patients preliminarily diagnosed Type-II diabetes mellitus on the basis of signs and symptoms of
  • disease will be confirmed by HbA1C, FBSL and PPBSL.

排除标准

  • Type-II DM with PTCA or CABG history.
  • Patient of Sahaja Prameha and having bala and dhatukshaya and Type – I Diabetes Mellitus.
  • Patient undergoing regular treatment for any other severe illness
  • patient suffering from tuberculosis, carcinoma, HIV positive patients
  • endocrine disorders like thyrotoxicosis, cushing syndrome, conn syndrome,hypothyroidism with Type II DM.
  • Patients suffering from malignant and accelerated hypertension, CVS disorders,
  • pregnant women and planning to be pregnant within six months
  • lactating mother
  • secondary diabetes mellitus, diabetes ketoacidosis, CNS disorder e.g. encephalopathy, seizures.
  • Auto-immune diseases.
  • MODY (Maturity Onset of Diabetes in Youngs)
  • Severe renal and hepatic failure.
  • Secondary diabetes mellitus.
  • History of acute and chronic pancreatitis.
  • Acute Type II DM complication like HHNK & hypoglycemia.
  • Diabetic under stress like infection, undergoing surgery, STEMI, NSTEMI,
  • stroke, Trauma, repeated hypoglycemia, diabetic wounds

研究者

发起方
Dr Snehalkumar Prakash Patil

相似试验